CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 1

Incompliant submissions 0

Total trials 1

My Organizations' Clinical Trials

Showing 1125 of 1710 entries

View as:

Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00964587 Org: User:

Start: 08/31/10 End: 02/28/14 Due: 02/28/15

Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy

Phase: N/A Priority: Normal

NCT ID: NCT03558204 Org: User:

Start: 08/01/18 End: 01/30/23 Due: 01/30/24

Differences in Cannabis Impairment and Its Measurement Due to Route of Administration

Phase: N/A Priority: Normal

NCT ID: NCT03122691 Org: User:

Start: 05/01/18 End: 02/01/20 Due: 02/01/21

Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis

Phase: N/A Priority: Normal

NCT ID: NCT01845467 Org: User:

Start: 02/28/13 End: 12/31/18 Due: 12/31/19

Dual Sensory Impairment Low Vision Rehabilitation (LVR) Initiative

Phase: N/A Priority: Normal

NCT ID: NCT03664349 Org: User:

Start: 11/26/18 End: 09/20/19 Due: 09/20/20

Contingency Outcomes in Prolonged Exposure

Phase: N/A Priority: Normal

NCT ID: NCT01693978 Org: User:

Start: 09/30/12 End: 09/30/15 Due: 09/30/16

Crizanlizumab for Treating COVID-19 Vasculopathy

Phase: N/A Priority: Normal

NCT ID: NCT04435184 Org: User:

Start: 07/09/20 End: 01/04/21 Due: 01/04/22

The Use of Eculizumab in HELLP Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT04103489 Org: User:

Start: 02/23/21 End: 09/04/23 Due: 09/04/24

deLIVER: Direct Acting Antiviral Effects on the Liver

Phase: N/A Priority: Normal

NCT ID: NCT02938013 Org: User:

Start: 01/31/17 End: 09/30/20 Due: 09/30/21

An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children

Phase: N/A Priority: Normal

NCT ID: NCT02985567 Org: User:

Start: 09/30/13 End: 11/30/16 Due: 11/30/17

Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline

Phase: N/A Priority: Normal

NCT ID: NCT03585907 Org: User:

Start: 09/02/19 End: 09/01/21 Due: 09/01/22

Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

Phase: N/A Priority: Normal

NCT ID: NCT00010413 Org: User:

Start: 04/30/99 End: - Due: -

Dietary Treatments for Cognitive Impairment in Older Adults

Phase: N/A Priority: Normal

NCT ID: NCT02521818 Org: User:

Start: 08/31/15 End: 07/01/19 Due: 07/01/20

SHARE: Sharing Healthcare Wishes in Primary Care

Phase: N/A Priority: Normal

NCT ID: NCT04593472 Org: User:

Start: 10/21/20 End: 02/26/25 Due: 02/26/26

Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

Phase: N/A Priority: Normal

NCT ID: NCT03828994 Org: User:

Start: 02/10/19 End: 03/31/26 Due: 03/31/27

Microfinance Intervention to Improve Health of Trauma Survivors in DRC

Phase: N/A Priority: Normal

NCT ID: NCT02008708 Org: User:

Start: 01/31/11 End: 09/30/16 Due: 09/30/17

Intervention Study to Control High Blood Pressure for Korean American

Phase: N/A Priority: Normal

NCT ID: NCT00473681 Org: User:

Start: 09/30/03 End: 08/31/07 Due: 08/31/08

Cognitive Effects of Nimodipine in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT03671525 Org: User:

Start: 10/05/18 End: 05/12/23 Due: 05/12/24

SOCIABLE Seniors Optimizing Community Integration to Advance Better Living With ESRD

Phase: N/A Priority: Normal

NCT ID: NCT03055273 Org: User:

Start: 06/30/16 End: 06/30/17 Due: 06/30/18

Five, Plus Nuts and Beans for Kidneys

Phase: N/A Priority: Normal

NCT ID: NCT03299816 Org: User:

Start: 02/22/18 End: 12/08/21 Due: 12/08/22

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Phase: N/A Priority: Normal

NCT ID: NCT00798590 Org: User:

Start: 12/31/08 End: 06/30/11 Due: 06/30/12

Structuring the Integration of Care Management Services For Medicaid Enrollees Recipients With Chronic Illness, Substance Abuse Problems and Possible Psychiatric Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00399373 Org: User:

Start: 11/30/05 End: 10/31/08 Due: 10/31/09

Supplementation With Omega-3: Mechanism of Action

Phase: N/A Priority: Normal

NCT ID: NCT02036307 Org: User:

Start: 04/30/13 End: 01/31/15 Due: 01/31/16

Pharmacogenomics of Antiplatelet Response - I

Phase: N/A Priority: Normal

NCT ID: NCT01815008 Org: User:

Start: 10/31/12 End: 06/30/14 Due: 06/30/15

Comparison of Two Methods of High Frequency Oscillatory Ventilation in Individuals With Acute Respiratory Distress Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00399581 Org: User:

Start: 11/30/06 End: 06/30/09 Due: 06/30/10

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes	NCT00964587	Johns Hopkins University	user2@example.com	None	2010-08-31	2014-02-28	2015-02-28	-	-	2025-07-14
Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy	NCT03558204	Johns Hopkins University	user2@example.com	None	2018-08-01	2023-01-30	2024-01-30	-	-	2025-07-14
Differences in Cannabis Impairment and Its Measurement Due to Route of Administration	NCT03122691	Johns Hopkins University	user2@example.com	None	2018-05-01	2020-02-01	2021-02-01	-	-	2025-07-14
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis	NCT01845467	Johns Hopkins University	user2@example.com	None	2013-02-28	2018-12-31	2019-12-31	-	-	2025-07-14
Dual Sensory Impairment Low Vision Rehabilitation (LVR) Initiative	NCT03664349	Johns Hopkins University	user2@example.com	None	2018-11-26	2019-09-20	2020-09-20	-	-	2025-07-14
Contingency Outcomes in Prolonged Exposure	NCT01693978	Johns Hopkins University	user2@example.com	None	2012-09-30	2015-09-30	2016-09-30	-	-	2025-07-14
Crizanlizumab for Treating COVID-19 Vasculopathy	NCT04435184	Johns Hopkins University	user2@example.com	None	2020-07-09	2021-01-04	2022-01-04	-	-	2025-07-14
The Use of Eculizumab in HELLP Syndrome	NCT04103489	Johns Hopkins University	user2@example.com	None	2021-02-23	2023-09-04	2024-09-04	-	-	2025-07-14
deLIVER: Direct Acting Antiviral Effects on the Liver	NCT02938013	Johns Hopkins University	user2@example.com	None	2017-01-31	2020-09-30	2021-09-30	-	-	2025-07-14
An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children	NCT02985567	Johns Hopkins University	user2@example.com	None	2013-09-30	2016-11-30	2017-11-30	-	-	2025-07-14
Feasibility and Efficacy of Dietary Interventions for Older Adults With Subjective Cognitive Decline	NCT03585907	Johns Hopkins University	user2@example.com	None	2019-09-02	2021-09-01	2022-09-01	-	-	2025-07-14
Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus	NCT00010413	Johns Hopkins University	user2@example.com	None	1999-04-30	-	-	-	-	2025-07-14
Dietary Treatments for Cognitive Impairment in Older Adults	NCT02521818	Johns Hopkins University	user2@example.com	None	2015-08-31	2019-07-01	2020-07-01	-	-	2025-07-14
SHARE: Sharing Healthcare Wishes in Primary Care	NCT04593472	Johns Hopkins University	user2@example.com	None	2020-10-21	2025-02-26	2026-02-26	-	-	2025-07-14
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II	NCT03828994	Johns Hopkins University	user2@example.com	None	2019-02-10	2026-03-31	2027-03-31	-	-	2025-07-14
Microfinance Intervention to Improve Health of Trauma Survivors in DRC	NCT02008708	Johns Hopkins University	user2@example.com	None	2011-01-31	2016-09-30	2017-09-30	-	-	2025-07-14
Intervention Study to Control High Blood Pressure for Korean American	NCT00473681	Johns Hopkins University	user2@example.com	None	2003-09-30	2007-08-31	2008-08-31	-	-	2025-07-14
Cognitive Effects of Nimodipine in Patients With Schizophrenia	NCT03671525	Johns Hopkins University	user2@example.com	None	2018-10-05	2023-05-12	2024-05-12	-	-	2025-07-14
SOCIABLE Seniors Optimizing Community Integration to Advance Better Living With ESRD	NCT03055273	Johns Hopkins University	user2@example.com	None	2016-06-30	2017-06-30	2018-06-30	-	-	2025-07-14
Five, Plus Nuts and Beans for Kidneys	NCT03299816	Johns Hopkins University	user2@example.com	None	2018-02-22	2021-12-08	2022-12-08	-	-	2025-07-14
The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients	NCT00798590	Johns Hopkins University	user2@example.com	None	2008-12-31	2011-06-30	2012-06-30	-	-	2025-07-14
Structuring the Integration of Care Management Services For Medicaid Enrollees Recipients With Chronic Illness, Substance Abuse Problems and Possible Psychiatric Disorders	NCT00399373	Johns Hopkins University	user2@example.com	None	2005-11-30	2008-10-31	2009-10-31	-	-	2025-07-14
Supplementation With Omega-3: Mechanism of Action	NCT02036307	Johns Hopkins University	user2@example.com	None	2013-04-30	2015-01-31	2016-01-31	-	-	2025-07-14
Pharmacogenomics of Antiplatelet Response - I	NCT01815008	Johns Hopkins University	user2@example.com	None	2012-10-31	2014-06-30	2015-06-30	-	-	2025-07-14
Comparison of Two Methods of High Frequency Oscillatory Ventilation in Individuals With Acute Respiratory Distress Syndrome	NCT00399581	Johns Hopkins University	user2@example.com	None	2006-11-30	2009-06-30	2010-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance